| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/11/2001 | CN1302887A Polypeptide-dyein light-medium chain 58 and polynucleotide for coding it |
| 07/11/2001 | CN1302884A Polypeptide-human eukaryote initiation factor 50 and polynucleotide for coding it |
| 07/11/2001 | CN1302883A Polypeptide-human enameling protein 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302814A Polypeptide-human S18 ribosomal protein 18 and polynucleotide for coding it |
| 07/11/2001 | CN1302813A Polypeptide-zinc finger protein 42 and polynucleotide for coding it |
| 07/11/2001 | CN1068335C Novel anti-neoplastic cytokine |
| 07/11/2001 | CA2331012A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/10/2001 | US6258936 SpoIIIE |
| 07/10/2001 | US6258935 Amino acid sequence of lymphocyte specific interferon regulatory factor, a type of transcription factor; recombinant expression of this polypeptide |
| 07/10/2001 | US6258929 Amino acid sequence of protein which binds presenilin 1; alzheimer's disease |
| 07/10/2001 | US6258603 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/10/2001 | US6258598 EBV-infected stomach cancer cell line |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258579 I-kappa-b kinase signalsome capable of specifically phosphorylating i-kappa-b-alpha and i-kappa-b-beta; antiinflammatory agents; anticarcinogenic agents; viricides; treatment of autoimmune and nervous system disorders |
| 07/10/2001 | US6258564 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method the hybirdomas and antigen proteins recognized by the antibodies |
| 07/10/2001 | US6258563 Increasing production of proteins in gram-positive microorganisms |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258561 Culturing cell transformed with vector which codes for fusion protein of ligand linked to peptide having cysteine at n-terminus and subjecting expressed protein to reaction which cleaves peptide bond on n-terminal side of cysteine |
| 07/10/2001 | US6258560 Using cell having nucleic acid encoding a phage lysozyme and gene t product, second nucleic acid encoding a dna-digesting protein linked to a signal sequence for secretion, and third nucleic acid encoding heterologous polypeptide |
| 07/10/2001 | US6258559 Incubating recombinant host which expresses peptide or polypeptide under control of alcohol-inducible promoter in a medium which includes sugar but not alcohol; soluble minimal medium prevents precipitation |
| 07/10/2001 | US6258552 Measuring adjustment in bone components; mix blood with solid carrier and preferential antibody, measuring the amount of the detectable marker immobilized on the solid carrier |
| 07/10/2001 | US6258547 Nucleic acid encoding amp-activated protein kinase |
| 07/10/2001 | US6258529 Nucleotide sequences coding antibody; for use in diagnosis and human therapy |
| 07/10/2001 | US6258364 Isolated carbohydrate epitope; immunocontraceptive vaccines; semen detection; medical diagnosis; antifertility agents |
| 07/10/2001 | US6258358 Targeted immunostimulation with bispecific reagents |
| 07/10/2001 | CA2214629C Receptor activation by gas6 |
| 07/10/2001 | CA2089395C Monoclonal antibodies for detecting water treatment polymers |
| 07/10/2001 | CA2060666C Antigenic epitopes present on membrane-bound but not secreted iga |
| 07/10/2001 | CA2047752C Hormone response element compositions and assay |
| 07/10/2001 | CA2032505C Coat transmembrane glycoprotein antigens of a hiv-2 type human retrovirus and antigens sharing immunological similarities |
| 07/05/2001 | WO2001048485A2 Selecting library members capable of binding to epitopes |
| 07/05/2001 | WO2001048228A1 Methods and materials relating to gene expression |
| 07/05/2001 | WO2001048215A1 RICE-ORIGIN GIBBERELLIN 2β-HYDROXYLASE GENES AND UTILIZATION THEREOF |
| 07/05/2001 | WO2001048209A2 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | WO2001048151A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | WO2001048150A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | WO2001048017A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047959A2 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001000822A3 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 07/05/2001 | WO2000073348A3 Methods and compositions for inhibiting neoplastic cell growth |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof |
| 07/05/2001 | WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/05/2001 | WO1999051625A9 Peptides causing formation of compact structures |
| 07/05/2001 | US20010007152 Obtained by immunizing transgenic mice which produce human leukocyte antigen (HLA) with tumor-associated antigens and recovering the nucleic acids encoding the T cell receptors from the cytotoxic T lymphocytes; diagnosis and therapy |
| 07/05/2001 | US20010007022 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free N-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 07/05/2001 | US20010007021 Monoclonal antibody, antigen-binding region of which competitively inhibits immunospecific binding of monoclonal antibody produced by hybridoma R7.6.2 having ATCC accession number 13 13 13 13 to target epitope; use in organ transplants |
| 07/05/2001 | US20010007020 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/05/2001 | US20010007019 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 07/05/2001 | US20010006939 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 07/05/2001 | US20010006816 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006815 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006814 Chemical modification |
| 07/05/2001 | US20010006798 Novel FtsL |
| 07/05/2001 | US20010006797 Transfection cell with genetic vector |
| 07/05/2001 | US20010006778 Methods for identifying compounds that bind to a target |
| 07/05/2001 | US20010006641 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 07/05/2001 | CA2396029A1 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope |
| 07/05/2001 | CA2395950A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | CA2395442A1 Methods and materials relating to gene expression |
| 07/05/2001 | CA2395335A1 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | CA2394807A1 Gibberellin 2.beta.-hydroxylase genes of rice and uses thereof |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/04/2001 | EP1112499A1 Method for detecting or quantifying basophils and eosinophils |
| 07/04/2001 | EP1112496A2 Diagnostic method for detecting disturbances of the pancreas |
| 07/04/2001 | EP1112382A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 07/04/2001 | EP1112372A1 Alternatively targeted adenovirus |
| 07/04/2001 | EP1112366A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112364A2 Stomach polypeptide zsig28 |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112360A1 Ecdysone receptors and methods for their use |
| 07/04/2001 | EP1112359A2 Enhanced functional expression of g protein-coupled receptors |
| 07/04/2001 | EP1112353A2 Recombinant protein production in urine |
| 07/04/2001 | EP1112351A2 Polymerase chimeras |
| 07/04/2001 | EP1112286A1 Secreted proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112285A1 Human chordin-related proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112282A2 Canine growth hormone secretagogue receptor |
| 07/04/2001 | EP1112085A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 07/04/2001 | EP1112078A2 New use |
| 07/04/2001 | EP0756708B1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation |
| 07/04/2001 | EP0679187B2 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 07/04/2001 | CN1302330A Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 07/04/2001 | CN1302305A Peptides causing formation of compact structure |
| 07/03/2001 | US6255554 Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor |
| 07/03/2001 | US6255472 Isolated nucleic acid molecule encoding a human skeletal muscle-specific receptor |
| 07/03/2001 | US6255471 CRFG-1b, a target and marker for chronic renal failure |
| 07/03/2001 | US6255467 Human blood bacterium |
| 07/03/2001 | US6255457 Immunoglobulin for use as diagnositic tool and in preferential drug delivery |
| 07/03/2001 | US6255456 Enzymatic polypeptide; for use in diagnosis, detection, prevention and treatment of cancer and immune defects |
| 07/03/2001 | US6255107 An antibody reacting with a cell surface antigen expressed on tryptase and chymase positive human mast cells; treatment of allergic disease, bronchial asthma, allergic rhinitis |
| 07/03/2001 | US6255105 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/03/2001 | US6255100 Cyclosporin fermentation process |
| 07/03/2001 | US6255096 An isolated nucleic acid encoding an amino acid; diagnosis and therapy for progressive mental retardation in conjuction with skeletal deformities |
| 07/03/2001 | US6255073 Cell segment from drosophila; for the treatment of cancer, tumors, viral or retroviral infection and autoimmune diseases |